Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

WHAT'S NEW

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Feb 21 2019

Full Issue

Trade Secret Lawsuit Continues To Tease Details Out Of Leaders For Secretive Health Initiative Funded By Billionaires

Testimony from Jack Stoddard, the venture's chief operating officer, reveals a focus on market efficiency and cost transparency. In one response, Stoddard boiled the initiative's mission down to this point: make health insurance intelligible. “It’s very difficult for the employees when we talk to them to be able to understand what’s covered, to afford their coverage." The lawsuit highlights just how nervous traditional health industry mainstays are about the new project founded by Amazon, Berkshire Hathaway, and J.P. Morgan Chase.

Stat: Unsealed Testimony Reveals A Goal Of Atul Gawande Venture: ‘Make Health Insurance Intelligible’

Making insurance intelligible is the core mission of the health care venture led by Atul Gawande and founded by Amazon, Berkshire Hathaway, and J.P. Morgan Chase, according to testimony unsealed on Wednesday from the venture’s chief operating officer. The COO, Jack Stoddard, also focused on the venture’s approach to prescription drug prices — and to the flaws and foibles of a notoriously opaque system. “You can imagine our employers are — just given who supports us — are incredibly allergic to market inefficiencies,” Stoddard said. (Sheridan, 2/20)

The Wall Street Journal: New Details Of Amazon, Berkshire Hathaway, JPMorgan Health Venture Emerge In Court Testimony

A health-care joint venture launched by Amazon.com Inc., Berkshire Hathaway Inc. and JPMorgan Chase & Co. is looking at how to redesign health insurance, among other efforts, according to newly unsealed court testimony from an executive at the health startup. The three companies announced the venture last year with stated goals of trying to improve health care and rein in costs for their employees. The still-unnamed venture has released few specifics, however, about its long-term aims. (Kamp and Wilde Mathews, 2/20)

Bloomberg: Buffett’s About To Reveal If His Cash Headache Found Any Relief 

[Charles] Munger has called health care one of the hardest tasks on Berkshire’s agenda. The company announced last year that it was teaming up with JPMorgan Chase & Co. and Amazon.com Inc. to tackle the problem for employees of the three companies.In June, the venture named Atul Gawande, a surgeon and journalist, to lead it and has since hired key employees. Buffett has said the effort will try to deliver better medical service at a lower cost, but has also acknowledged the challenges. The trio haven’t divulged too many secrets about how the venture is working, so any commentary from Buffett could influence investors’ perceptions on the push. Signs of success would reverberate throughout the industry. (Chiglinsky, 2/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF